Chromaffin-tissue Derived Tumors
1 clinical trials · Condition
◉ Watch Chromaffin-tissue Derived Tumors
| Record | Firm | Date |
|---|---|---|
| Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot (NCT00875407) | Assistance Publique Hopitaux De Marseille | 2009-02-01 |
Track Chromaffin-tissue Derived Tumors automatically
Every clearance here is in the API, with alerts when new ones post.